Pharma-Bio Serv (OTCMKTS:PBSV) Stock Passes Below Two Hundred Day Moving Average – What’s Next?

Shares of Pharma-Bio Serv, Inc. (OTCMKTS:PBSVGet Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.65 and traded as low as $0.55. Pharma-Bio Serv shares last traded at $0.58, with a volume of 5,450 shares changing hands.

Pharma-Bio Serv Stock Down 6.5 %

The stock has a market capitalization of $13.32 million, a P/E ratio of -19.33 and a beta of 0.57. The company has a 50-day moving average price of $0.61 and a two-hundred day moving average price of $0.65.

Pharma-Bio Serv (OTCMKTS:PBSVGet Free Report) last announced its quarterly earnings results on Monday, September 16th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.03 by ($0.04). The firm had revenue of $2.42 million during the quarter, compared to the consensus estimate of $3.50 million. Pharma-Bio Serv had a negative net margin of 7.81% and a negative return on equity of 5.81%.

Pharma-Bio Serv Company Profile

(Get Free Report)

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.

Featured Stories

Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.